Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Orphan Drug Pricing: More Dialogue And Collaboration Needed, Says EURORDIS

Executive Summary

Pharmaceutical companies, payers and other stakeholders need to work more collaboratively if the problems surrounding the pricing and reimbursement of orphan medicines are to be tackled successfully in Europe, says the rare disease organization EURORDIS.

Advertisement

Related Content

"Crazy" European Orphan Drug Pricing System Has To End
Witty On Pricing: Oncology 'No Safe Haven'

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register